1.Efficacy and safety of dye-free submucosal injection solution for gastric endoscopic submucosal dissection
Wan LU ; Yonggang DING ; Ting ZHANG ; Lijuan MAO ; Jing CHEN ; Yuhong ZHOU ; Jun XIAO ; Wenjie LI ; Yaohui WANG ; Qide ZHANG
Chinese Journal of Digestive Endoscopy 2025;42(10):823-827
To evaluate the efficacy and safety of dye-free submucosal injection solution for gastric endoscopic submucosal dissection (ESD), a retrospective cohort study was performed on data of inpatients with early gastric cancer and precancerous lesions who underwent ESD at the Digestive Endoscopy Center of Jiangsu Province Hospital of Traditional Chinese Medicine from January to December 2020. Cases were divided into dye-free submucosal injection solution group (the observation group) and dye-containing solution group (the control group). A total of 108 cases met the eligibility criteria for analysis (39 VS 69). Baseline characteristics were comparable between the two groups ( P>0.05). Compared with the control group, the observation group showed similar median procedure time (30.5 min VS 35.0 min), median dissection speed (0.3 cm2/min VS 0.4 cm2/min), mean volume of injection solution used (39.2 mL VS 38.8 mL), en bloc resection rate [100.0% (39/39) VS 98.6% (68/69)], and curative resection rate [97.4% (38/39) VS 97.1% (67/69)] (all P>0.05). Postoperative stay was 3.0±0.8 days in the observation group and 3.2±0.8 days in the control group ( t=-0.908, P=0.378). Delayed bleeding occurred in 3 (7.7%) patients VS 2 (2.9%) patients ( P=0.349), and postoperative infection occurred in 3 (7.7%) patients VS 8 (11.6%) patients ( P=0.743), respectively. In gastric ESD, dye-free submucosal injection solution demonstrates efficacy comparable with dye-containing solution and does not appreciably increase the incidence of intraoperative or postoperative complications.
2.Efficacy and safety of dye-free submucosal injection solution for gastric endoscopic submucosal dissection
Wan LU ; Yonggang DING ; Ting ZHANG ; Lijuan MAO ; Jing CHEN ; Yuhong ZHOU ; Jun XIAO ; Wenjie LI ; Yaohui WANG ; Qide ZHANG
Chinese Journal of Digestive Endoscopy 2025;42(10):823-827
To evaluate the efficacy and safety of dye-free submucosal injection solution for gastric endoscopic submucosal dissection (ESD), a retrospective cohort study was performed on data of inpatients with early gastric cancer and precancerous lesions who underwent ESD at the Digestive Endoscopy Center of Jiangsu Province Hospital of Traditional Chinese Medicine from January to December 2020. Cases were divided into dye-free submucosal injection solution group (the observation group) and dye-containing solution group (the control group). A total of 108 cases met the eligibility criteria for analysis (39 VS 69). Baseline characteristics were comparable between the two groups ( P>0.05). Compared with the control group, the observation group showed similar median procedure time (30.5 min VS 35.0 min), median dissection speed (0.3 cm2/min VS 0.4 cm2/min), mean volume of injection solution used (39.2 mL VS 38.8 mL), en bloc resection rate [100.0% (39/39) VS 98.6% (68/69)], and curative resection rate [97.4% (38/39) VS 97.1% (67/69)] (all P>0.05). Postoperative stay was 3.0±0.8 days in the observation group and 3.2±0.8 days in the control group ( t=-0.908, P=0.378). Delayed bleeding occurred in 3 (7.7%) patients VS 2 (2.9%) patients ( P=0.349), and postoperative infection occurred in 3 (7.7%) patients VS 8 (11.6%) patients ( P=0.743), respectively. In gastric ESD, dye-free submucosal injection solution demonstrates efficacy comparable with dye-containing solution and does not appreciably increase the incidence of intraoperative or postoperative complications.
3.The Association between Educational Attainment and the Risk of Nonalcoholic Fatty Liver Disease among Chinese Adults: Findings from the REACTION Study
Yuanyue ZHU ; Long WANG ; Lin LIN ; Yanan HUO ; Qin WAN ; Yingfen QIN ; Ruying HU ; Lixin SHI ; Qing SU ; Xuefeng YU ; Li YAN ; Guijun QIN ; Xulei TANG ; Gang CHEN ; Shuangyuan WANG ; Hong LIN ; Xueyan WU ; Chunyan HU ; Mian LI ; Min XU ; Yu XU ; Tiange WANG ; Zhiyun ZHAO ; Zhengnan GAO ; Guixia WANG ; Feixia SHEN ; Xuejiang GU ; Zuojie LUO ; Li CHEN ; Qiang LI ; Zhen YE ; Yinfei ZHANG ; Chao LIU ; Youmin WANG ; Shengli WU ; Tao YANG ; Huacong DENG ; Lulu CHEN ; Tianshu ZENG ; Jiajun ZHAO ; Yiming MU ; Weiqing WANG ; Guang NING ; Yufang BI ; Yuhong CHEN ; Jieli LU
Gut and Liver 2024;18(4):719-728
Background/Aims:
Low educational attainment is a well-established risk factor for nonalcoholic fatty liver disease (NAFLD) in developed areas. However, the association between educational attainment and the risk of NAFLD is less clear in China.
Methods:
A cross-sectional study including over 200,000 Chinese adults across mainland China was conducted. Information on education level and lifestyle factors were obtained through standard questionnaires, while NAFLD and advanced fibrosis were diagnosed using validated formulas. Outcomes included the risk of NAFLD in the general population and high probability of fibrosis among patients with NAFLD. Logistic regression analysis was employed to estimate the risk of NAFLD and fibrosis across education levels. A causal mediation model was used to explore the potential mediators.
Results:
Comparing with those receiving primary school education, the multi-adjusted odds ratios (95% confidence intervals) for NAFLD were 1.28 (1.16 to 1.41) for men and 0.94 (0.89 to 0.99) for women with college education after accounting for body mass index. When considering waist circumference, the odds ratios (95% CIs) were 0.94 (0.86 to 1.04) for men and 0.88 (0.80 to 0.97) for women, respectively. The proportions mediated by general and central obesity were 51.00% and 68.04% for men, while for women the proportions were 48.58% and 32.58%, respectively. Furthermore, NAFLD patients with lower educational attainment showed an incremental increased risk of advanced fibrosis in both genders.
Conclusions
In China, a low education level was associated with a higher risk of prevalent NAFLD in women, as well as high probability of fibrosis in both genders.
4.Corrigendum to: The Association between Educational Attainment and the Risk of Nonalcoholic Fatty Liver Disease among Chinese Adults: Findings from the REACTION Study
Yuanyue ZHU ; Long WANG ; Lin LIN ; Yanan HUO ; Qin WAN ; Yingfen QIN ; Ruying HU ; Lixin SHI ; Qing SU ; Xuefeng YU ; Li YAN ; Guijun QIN ; Xulei TANG ; Gang CHEN ; Shuangyuan WANG ; Hong LIN ; Xueyan WU ; Chunyan HU ; Mian LI ; Min XU ; Yu XU ; Tiange WANG ; Zhiyun ZHAO ; Zhengnan GAO ; Guixia WANG ; Feixia SHEN ; Xuejiang GU ; Zuojie LUO ; Li CHEN ; Qiang LI ; Zhen YE ; Yinfei ZHANG ; Chao LIU ; Youmin WANG ; Shengli WU ; Tao YANG ; Huacong DENG ; Lulu CHEN ; Tianshu ZENG ; Jiajun ZHAO ; Yiming MU ; Weiqing WANG ; Guang NING ; Yufang BI ; Yuhong CHEN ; Jieli LU
Gut and Liver 2024;18(5):926-927
5.Anti-Helicobacter pylori Mechanism of Chinese Medicine: A Review
Huiying WAN ; Chao LI ; Wei LI ; Xinbo SONG ; Lijuan ZHANG ; Yuhong BIAN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(3):203-212
Helicobacter pylori (Hp), a spiral-shaped microaerophilic Gram-negative bacterium that has been classified as a class Ⅰ carcinogen by the World Health Organization, is associated with a variety of digestive system diseases. With the popularization of antibiotic therapy, Hp resistance has become the main reason for the failure of the eradication treatment of Hp. A variety of Chinese medicines have been proved to have anti-Hp effects, which are expected to serve as new options for the eradication of Hp. By reviewing the recent literature in China and abroad, we summarized the understanding of Chinese medicines in the treatment of Hp infection and elaborated on the mechanisms from two aspects: direct killing and indirect inhibition. On the one hand, Chinese medicines can directly kill Hp by inhibiting the growth, respiration, and metabolism of Hp, destroying the morphological structure of Hp, and inhibiting the formation of Hp biofilm. On the other hand, Chinese medicines can inhibit Hp by reducing Hp adhesion and colonization, regulating Hp-caused immune response, inhibiting Hp-caused inflammation, and alleviating the Hp-caused oxidative stress and gastric mucosal injury. Specifically, the indirect inhibition of Hp can be achieved via the following ways. Chinese medicines can reduce Hp adhesion and colonization by reducing Hp motility, inhibiting urease activity and the expression of related genes, and decreasing the production of adhesion proteins. They can regulate the Hp-caused immune responses by enhancing the immune protective response, modulating lysosomal function and immune cytokines, avoiding the immune evasion of Hp, and maintaining the balance between immunity and inflammation. Chinese medicines can inhibit Hp-caused inflammatory responses by inhibiting the release of inflammatory cytokines, down-regulating the expression of virulence factors, and regulating the targets and signaling pathways in the treatment of inflammation. In addition, Chinese medicines can alleviate the Hp-caused oxidative stress and gastric mucosal injury by improving the activities of antioxidant enzymes and oxidases, regulating the generation of reactive oxygen species and reactive nitrogen, and inhibiting inflammatory mediators. This article systematically introduces the mechanisms of Chinese medicines against Hp, aiming to provide a theoretical and scientific basis for the research and clinical application of Chinese medicines against Hp.
6.Rethinking of neoadjuvant therapy for patients with initially resectable colorectal cancer liver metastases
Gong CHEN ; Yuhong LI ; Rongxin ZHANG ; Binkui LI ; Fulong WANG ; Yunfei YUAN ; Zhizhong PAN ; Desen WAN
Chinese Journal of Hepatobiliary Surgery 2020;26(7):488-492
Surgical resection is the best method for patients with colorectal cancer liver metastases. However, tumor recurrence rate is still high after surgery. Preoperative chemotherapy can help shrink the tumor, test biological behavior, and reduce recurrence rate; but it may also cause liver injury and delay surgery. There is still controversy whether neoadjuvant chemotherapy should be performed and how to select patients from chemotherapy before surgery. Thus, in this article, combined the research progress and the clinical experience of author's center, we discuss this issue in 4 aspects: the development of neoadjuvant chemotherapy; the indications and guideline recommendation for neoadjuvant chemotherapy; the selection of neoadjuvant chemotherapy regimens; common problems in neoadjuvant chemotherapy.
7. Study on the efficacy of neonatal HBsAg content in venous blood to predict mother-to-children transmission of hepatitis B virus
Chongping RAN ; Lu ZHANG ; Minghui LI ; Wei YI ; Yao LU ; Mingfang ZHOU ; Yuhong HU ; Yuanyuan LIU ; Gang WAN ; Junnan LI ; Yao XIE
Chinese Journal of Experimental and Clinical Virology 2019;33(4):419-423
Objective:
To investigate the role of HBsAg status and content in neonatal venous blood to predict HBV mother-to-children transmission.
Methods:
The study candidates from a prospective study about HBV mother-to-children transmission blocking who were hepatitis B surface antigen (HBsAg) positivity, hepatitis B e antigen (HBeAg) positivity, and HBV DNA levels >105 IU/ml.All of their infants were enrolled.200 IU of hepatitis B immunoglobulin (HBIG)was injected within 6 hours after birth, and 200 IU HBIG was voluntarily selected 1 month after birth.All infants according to 0-1-6 month standard procedure were given 10 or 20 μg of hepatitis B vaccine. Pregnancy women before birth, and infants at the time of birth, 1-month and 7-month after birth, venous blood was tested for HBV virus and serological markers to assess the association with success of mother-to-children transmission blocking.
Results:
530 pregnant women and 530 neonates were enrolled. 60.75% at birth and 86.02% at birth for one month children were HBsAg-negative. The successful transmission in HBsAg-negative neonates was 100.00%. According to the receiver operating characteristic curve, the AUC of HBsAg content≥0.35 IU/ml at birth predicted to block failure was 0.979. The sensitivity was 85.60%, and the specificity was 100.00%. The AUC of HBsAg content≥0.18 IU/ ml at one month after birth predicted to block failure was 0.988, the sensitivity was 89.40%, and the specificity was 100.00%.
Conclusions
The HBsAg level in venous blood at birth and 1 month after birth can predict the failure of HBV mother-to-children transmission, and the neonates with HBsAg positivity in venous blood are a high-risk group that may block failure.
8.The off-label prescribing drugs of inpatients with nonorganic sleep disorders
Su HONG ; Li KUANG ; Qi ZHANG ; Jinglan HE ; Liyang WAN ; Xiaosha YANG ; Shuo DAI ; Jian WEN ; Tong WU ; Sijing CHEN ; Daqin DING ; Mengyao WANG ; Yuhong LI ; Muni XIAO ; Lan HU
Chinese Journal of Psychiatry 2019;52(3):188-192
Objective To understand the current situation of the use of psychotropic drug off-label prescribing for nonorganic sleep disorder patients,and to provide evidence for the development of the expert consensus on off-label prescribing of psychoactive drugs in psychiatry.Methods Patients discharged in 2017 with nonorganic sleep disorders were enrolled in the study.The off-labelled prescribing of psychoactive drugs questionnaire was used to investigate the records retrospectively.The off-label prescribing situation was confirmed by the drug label in China.Results A total of 294 patients were enrolled.The total rate of off-labelled prescription was 70.1% (206/294),the rate of off-labelled indication was 68.4% (201/294),the rate of off-labelled population was 14.3%(41/294),and the rate of off-labelled dose was 5.4% (16/294).Conclusion Off-label usage of psychotropic drugs is common and to standarize off-label prescribing with close supervision should be considered.
9.The off-label prescribing drugs of inpatients with nonorganic sleep disorders
Su HONG ; Li KUANG ; Qi ZHANG ; Jinglan HE ; Liyang WAN ; Xiaosha YANG ; Shuo DAI ; Jian WEN ; Tong WU ; Sijing CHEN ; Daqin DING ; Mengyao WANG ; Yuhong LI ; Muni XIAO ; Lan HU
Chinese Journal of Psychiatry 2019;52(3):188-192
Objective To understand the current situation of the use of psychotropic drug off-label prescribing for nonorganic sleep disorder patients,and to provide evidence for the development of the expert consensus on off-label prescribing of psychoactive drugs in psychiatry.Methods Patients discharged in 2017 with nonorganic sleep disorders were enrolled in the study.The off-labelled prescribing of psychoactive drugs questionnaire was used to investigate the records retrospectively.The off-label prescribing situation was confirmed by the drug label in China.Results A total of 294 patients were enrolled.The total rate of off-labelled prescription was 70.1% (206/294),the rate of off-labelled indication was 68.4% (201/294),the rate of off-labelled population was 14.3%(41/294),and the rate of off-labelled dose was 5.4% (16/294).Conclusion Off-label usage of psychotropic drugs is common and to standarize off-label prescribing with close supervision should be considered.
10.The establishment and application of graded management under early warning for intrahospital transport
Lin WAN ; Suhua SHI ; Rong HUANG ; Yue KONG ; Tingting YIN ; Yuhong CHENG
Chinese Journal of Nursing 2017;52(1):59-62
Objective Through conducting the project of quality improvement for intrahospital transport of critically ill patients from ward to ICU,to establish graded management under early warning to improve transport efficiency and quality.Methods Through setting up project team,setting goals of quality improvement,measuring and analyzing transport status,the graded management under early warning was established from three aspects:condition,equipment and transport personnel.The graded management under early warning was applied to clinical nursing practice to evaluate the effects.Results There was no statistical difference before and after the implementation of graded management under early warning in gender,age and condition of critical ill patients between two groups,but the time of transport was significantly reduced after the implementation,while there was no equipment failure,and the incidence of adverse events associated with devices decreased effectively.Conclusion The establishment and application of graded management under early warning has effectively reduced the risks of transport,improved efficiency and quality of transport.

Result Analysis
Print
Save
E-mail